Skip to content

Stock-Based Comp at other companies

Humana logo
HumanaHUM
$51M+4.1%
CVS Health logo
CVS HealthCVS
$266M+111%
UnitedHealth Group logo
UnitedHealth GroupUNH
$348M-7.2%
Agilon Health logo
Agilon HealthAGL
$6.26M-62.6%
Astrana Health logo
Astrana HealthASTH
$9.9M+26.7%
Aveanna Healthcare Holdings Inc. logo
Aveanna Healthcare Holdings Inc.AVAH
$4.15M-62.3%

Other financials

Income statement

See full
Revenue$251.9M+15.5%
Operating income-$29.1M-186%
Net income-$29.5M-159%
EPS (diluted)-$0.22-175%

Balance sheet

See full
Cash & equivalents$95.5M+58.0%
Total debt$93.8M-11.0%
Total equity$229.0M-3.8%
Total assets$547.4M+2.0%

Cash flow

See full
Operating cash flow$18.1M-26.3%
CapEx$3.6M+24.3%
Free cash flow$14.5M-33.1%

Valuation

See full
Market cap$1.31B+167%
Enterprise value$1.31B+146%
P/S1.4×+0.8×

Profitability

See full
Operating margin-1%-0.4pp
Net margin-1.2%-0.5pp
FCF margin4.5%+2.6pp

Returns & leverage

See full
Return on equity-5%-1.8pp
Debt / equity0.4×0.0×
Current ratio+0.3×

Where this comes from

Reported directly by InnovAge Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: InnovAge Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about InnovAge Holdings, Inc.'s stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is InnovAge Holdings, Inc.'s stock-based comp?
InnovAge Holdings, Inc. (INNV) reported stock-based comp of $1.79M in Q1 2026.
How has InnovAge Holdings, Inc.'s stock-based comp changed year-over-year?
InnovAge Holdings, Inc.'s stock-based comp decreased by 12.0% year-over-year, from $2.03M to $1.79M.
What is the long-term trend for InnovAge Holdings, Inc.'s stock-based comp?
Over 4 years (2021 to 2025), InnovAge Holdings, Inc.'s stock-based comp has grown at a 46.3% compound annual growth rate (CAGR), from $1.66M to $7.62M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.